EDGAR Filing Documents for 0001213900-21-048214

Form 8-K - Current report:

SEC Accession No. 0001213900-21-048214

Filing Date

2021-09-15

Accepted

2021-09-15 16:05:45

Documents

Period of Report

2021-09-09

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	ea146977-8k_clarusthera.htm iXBRL	8-K	186411
2	SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY	ea146977ex3-1_clarus.htm	EX-3.1	43807
3	AMENDED AND RESTATED BYLAWS OF THE COMPANY	ea146977ex3-2_clarus.htm	EX-3.2	124797
4	REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 9, 2021, BY AND AMONG THE COMPANY	ea146977ex4-1_clarus.htm	EX-4.1	150589
5	FORM OF INDEMNIFICATION AGREEMENT (DIRECTORS)	ea146977ex10-2_clarus.htm	EX-10.2	107606
6	FORM OF INDEMNIFICATION AGREEMENT (OFFICERS)	ea146977ex10-3_clarus.htm	EX-10.3	106844
7	EMPLOYMENT AGREEMENT, DATED SEPTEMBER 9, 2021, BY AND BETWEEN CLARUS THERAPEUTIC	ea146977ex10-4_clarus.htm	EX-10.4	153374
8	EMPLOYMENT AGREEMENT, DATED SEPTEMBER 9, 2021, BY AND BETWEEN CLARUS THERAPEUTIC	ea146977ex10-5_clarus.htm	EX-10.5	152905
9	EMPLOYMENT AGREEMENT, DATED SEPTEMBER 9, 2021, BY AND BETWEEN CLARUS THERAPEUTIC	ea146977ex10-6_clarus.htm	EX-10.6	127190
10	EMPLOYMENT AGREEMENT, DATED SEPTEMBER 9, 2021, BY AND BETWEEN CLARUS THERAPEUTIC	ea146977ex10-7_clarus.htm	EX-10.7	129102
11	FORMS OF AWARD AGREEMENTS UNDER THE 2021 STOCK OPTION AND INCENTIVE PLAN	ea146977ex10-9_clarus.htm	EX-10.9	219019
12	SUPPLEMENTAL INDENTURE NO. 2, DATED SEPTEMBER 9, 2021 BY AND BETWEEN CLARUS THER	ea146977ex10-15_clarus.htm	EX-10.15	46886
13	MARCUM'S LETTER TO THE SECURITIES AND EXCHANGE COMMISSION, DATED SEPTEMBER 15, 2	ea146977ex16-1_clarus.htm	EX-16.1	3353
14	UNAUDITED INTERIM FINANCIAL STATEMENTS OF LEGACY CLARUS AS OF AND FOR THE SIX MO	ea146977ex99-1_clarus.htm	EX-99.1	281481
15	MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA	ea146977ex99-2_clarus.htm	EX-99.2	168054
16	UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION OF THE COMPANY AS O	ea146977ex99-3_clarus.htm	EX-99.3	311128
	Complete submission text file	0001213900-21-048214.txt		2958126

Data Files

Seq	Description	Document	Type	Size
17	XBRL SCHEMA FILE	crxt-20210909.xsd	EX-101.SCH	3846
18	XBRL DEFINITION FILE	crxt-20210909_def.xml	EX-101.DEF	28800
19	XBRL LABEL FILE	crxt-20210909_lab.xml	EX-101.LAB	38636
20	XBRL PRESENTATION FILE	crxt-20210909_pre.xml	EX-101.PRE	27003
21	EXTRACTED XBRL INSTANCE DOCUMENT	ea146977-8k_clarusthera_htm.xml	XML	7232

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062

Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300

Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)